Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer.

Multiparametric magnetic resonance (MR) imaging of the prostate combines both morphological and functional MR techniques by utilizing small field of view T1-weighted, T2-weighted, diffusion-weighted imaging, dynamic contrast-enhanced imaging, and MR spectroscopy to accurately detect, localize, and stage primary and recurrent prostate cancer. Localizing the site of recurrence in patients with rising prostate-specific antigen following treatment affects decision making regarding treatment and can be accomplished with multiparametric prostate MR. Several different treatment options are available for prostate cancer including radical prostatectomy, external beam radiation therapy, brachytherapy, androgen deprivation therapy, or a number of focal therapy techniques. The findings of recurrent prostate cancer can be different depending on the treatment the patient has received, and the radiologist must be able to recognize the variety of imaging findings seen with this common disease. This review article will detail the findings of recurrent prostate cancer on multiparametric MR and describe common posttreatment changes which may create challenges to accurate interpretation.

Journal of clinical imaging science. 2016 Apr 29*** epublish ***

Daniel Corey Oppenheimer, Eric P Weinberg, Gary M Hollenberg, Steven P Meyers

Department of Imaging Sciences, University of Rochester Medical Center, Rochester, NY, USA., Department of Imaging Sciences, University of Rochester Medical Center, Rochester, NY, USA., Department of Imaging Sciences, University of Rochester Medical Center, Rochester, NY, USA., Department of Imaging Sciences, University of Rochester Medical Center, Rochester, NY, USA.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe